Burgdorf - With effect from 1 July 2007 and at a cost of around EUR 11 million (approx. CHF 18 million), Ypsomed has bought 100% of the shares in Florian Müller Holding GmbH, thus providing nationwide coverage in diabetes direct sales and distribution throughout Germany, with the focus on the care of insulin pump patients. With the acquisition of Florian Müller Ypsomed is consolidating its position in the strategically important diabetes business and, is diversifying its future sales base by around EUR 22 million (approx. CHF 36 million).
Press Releases Ypsomed Group